Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Receives Average Rating of “Buy” from Analysts

Shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX) have been assigned an average rating of “Buy” from the six analysts that are covering the stock, MarketBeat.com reports. Four equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating on the company. The average 1 year target price among brokerages that have covered the stock in the last year is $8.63.

BIOX has been the topic of several recent research reports. Lake Street Capital reduced their price target on Bioceres Crop Solutions from $13.00 to $8.00 and set a “buy” rating on the stock in a research report on Friday, February 7th. Canaccord Genuity Group reduced their price target on Bioceres Crop Solutions from $7.00 to $6.50 and set a “buy” rating on the stock in a research report on Thursday, February 13th. Finally, Oppenheimer reduced their price target on Bioceres Crop Solutions from $8.00 to $7.00 and set an “outperform” rating on the stock in a research report on Tuesday, April 22nd.

Bioceres Crop Solutions Stock Up 2.2%

NASDAQ BIOX opened at $4.63 on Monday. The stock has a fifty day moving average of $4.35 and a 200-day moving average of $5.47. The stock has a market capitalization of $290.35 million, a P/E ratio of 231.62 and a beta of 0.40. Bioceres Crop Solutions has a 52 week low of $3.51 and a 52 week high of $11.86. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.96 and a current ratio of 1.33.

Bioceres Crop Solutions (NASDAQ:BIOX) last released its earnings results on Wednesday, May 21st. The company reported ($0.02) EPS for the quarter, beating the consensus estimate of ($0.10) by $0.08. The company had revenue of $59.60 million during the quarter, compared to analysts’ expectations of $61.80 million. Bioceres Crop Solutions had a return on equity of 0.68% and a net margin of 0.58%. On average, equities research analysts forecast that Bioceres Crop Solutions will post -0.05 EPS for the current year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. JPMorgan Chase & Co. lifted its holdings in Bioceres Crop Solutions by 49.3% during the third quarter. JPMorgan Chase & Co. now owns 89,973 shares of the company’s stock worth $708,000 after acquiring an additional 29,693 shares in the last quarter. Stifel Financial Corp lifted its holdings in Bioceres Crop Solutions by 51.9% during the fourth quarter. Stifel Financial Corp now owns 61,958 shares of the company’s stock worth $377,000 after acquiring an additional 21,168 shares in the last quarter. Ballast Asset Management LP lifted its holdings in Bioceres Crop Solutions by 23.5% during the fourth quarter. Ballast Asset Management LP now owns 431,887 shares of the company’s stock worth $2,620,000 after acquiring an additional 82,187 shares in the last quarter. Fourth Sail Capital LP lifted its holdings in Bioceres Crop Solutions by 16.6% during the fourth quarter. Fourth Sail Capital LP now owns 3,698,961 shares of the company’s stock worth $22,490,000 after acquiring an additional 527,859 shares in the last quarter. Finally, Maven Securities LTD bought a new position in Bioceres Crop Solutions during the fourth quarter worth about $152,000. 17.68% of the stock is currently owned by institutional investors.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.